Expert-based collaborative analysis of the situation and prospects of biomarker test implementation in oncology in Spain

ConclusionsThe potential of Precision Medicine has not been fulfilled in Spain. While several regional initiatives are in place, a national plan or strategy around Precision Medicine and use of biomarkers is lacking. In a general context of rapid progress at a global and European level, including the 2021 Europe ’s Beating Cancer Plan, it is time to define and implement a National Plan to make the promise come true. While some comparable countries within Europe – such as the UK or France – are mature enough to adopt such strategies, in Spain there is still a long way to go. We consider tha t the different strands of work outlined in the Roadmap can be used as basis for such purpose.
Source: Clinical and Translational Oncology - Category: Cancer & Oncology Source Type: research